CGGBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.660420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.182400E-01
Normal-vs-Stage2
1.780410E-02
Normal-vs-Stage3
3.351900E-02
Normal-vs-Stage4
5.698600E-01
Stage1-vs-Stage2
9.967800E-01
Stage1-vs-Stage3
1.176990E-01
Stage1-vs-Stage4
3.345000E-01
Stage2-vs-Stage3
8.886400E-02
Stage2-vs-Stage4
1.521030E-01
Stage3-vs-Stage4
7.041700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.701600E-02
Normal-vs-AfricanAmerican
1.528810E-01
Normal-vs-Asian
2.529500E-02
Caucasian-vs-AfricanAmerican
8.784000E-01
Caucasian-vs-Asian
2.386000E-01
AfricanAmerican-vs-Asian
4.008400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.045800E-02
Normal-vs-Female
1.917880E-02
Male-vs-Female
4.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.195600E-01
Normal-vs-Age(41-60Yrs)
8.377700E-02
Normal-vs-Age(61-80Yrs)
9.935700E-03
Normal-vs-Age(81-100Yrs)
4.941500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.080200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.835400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.888630E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.483880E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.519800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.254000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.297400E-03
Normal-vs-Daily Drinker
4.480600E-03
Normal-vs-Weekly Drinker
2.228400E-02
Normal-vs-Occasional Drinker
1.463350E-01
Normal-vs-Social Drinker
1.353170E-01
Non Drinker-vs-Daily Drinker
6.335200E-01
Non Drinker-vs-Weekly Drinker
9.119200E-01
Non Drinker-vs-Occasional Drinker
8.586300E-02
Non Drinker-vs-Social Drinker
1.439830E-01
Daily Drinker-vs-Weekly Drinker
6.178600E-01
Daily Drinker-vs-Occasional Drinker
5.024300E-02
Daily Drinker-vs-Social Drinker
8.521500E-02
Weekly Drinker-vs-Occasional Drinker
2.019800E-01
Weekly Drinker-vs-Social Drinker
2.751000E-01
Occasional Drinker-vs-Social Drinker
8.815600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.174400E-01
Normal-vs-Grade 2
5.211600E-02
Normal-vs-Grade 3
5.947700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.917210E-01
Grade 1-vs-Grade 3
8.810000E-02
Grade 1-vs-Grade 4
2.174400E-01
Grade 2-vs-Grade 3
3.468600E-01
Grade 2-vs-Grade 4
5.211600E-02
Grade 3-vs-Grade 4
5.947700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.473630E-02
Normal-vs-NonDiabetic
6.684900E-03
Diabetic-vs-NonDiabetic
6.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.299600E-01
Normal-vs-NoPancreatitis
1.002430E-02
Pancreatitis-vs-NoPancreatitis
9.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.805800E-02
Normal-vs-N1
1.554440E-02
N0-vs-N1
6.778600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.266000E-02
Normal-vs-TP53-NonMutant
6.052100E-02
TP53-Mutant-vs-TP53-NonMutant
5.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
